vs
Side-by-side financial comparison of ALBANY INTERNATIONAL CORP (AIN) and P3 Health Partners Inc. (PIII). Click either name above to swap in a different company.
P3 Health Partners Inc. is the larger business by last-quarter revenue ($384.8M vs $321.2M, roughly 1.2× ALBANY INTERNATIONAL CORP). ALBANY INTERNATIONAL CORP runs the higher net margin — 4.3% vs -19.6%, a 23.9% gap on every dollar of revenue. On growth, ALBANY INTERNATIONAL CORP posted the faster year-over-year revenue change (12.0% vs 3.8%). Over the past eight quarters, ALBANY INTERNATIONAL CORP's revenue compounded faster (1.2% CAGR vs -0.5%).
Albany International Corp is a global advanced materials and industrial technology company. It operates two core segments: Machine Clothing producing custom engineered fabrics for paper and other industrial manufacturing processes, and Engineered Composites developing high-performance composite components primarily for the aerospace and defense sectors, serving customers across North America, Europe, Asia and other global regions.
P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.
AIN vs PIII — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $321.2M | $384.8M |
| Net Profit | $13.9M | $-75.5M |
| Gross Margin | 31.1% | — |
| Operating Margin | 9.3% | -40.0% |
| Net Margin | 4.3% | -19.6% |
| Revenue YoY | 12.0% | 3.8% |
| Net Profit YoY | -21.5% | -28.8% |
| EPS (diluted) | $0.56 | $-23.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $321.2M | $384.8M | ||
| Q3 25 | $261.4M | $345.3M | ||
| Q2 25 | $311.4M | $355.8M | ||
| Q1 25 | $288.8M | $373.2M | ||
| Q4 24 | $286.9M | $370.7M | ||
| Q3 24 | $298.4M | $362.1M | ||
| Q2 24 | $332.0M | $379.2M | ||
| Q1 24 | $313.3M | $388.5M |
| Q4 25 | $13.9M | $-75.5M | ||
| Q3 25 | $-97.8M | $-31.6M | ||
| Q2 25 | $9.2M | $-20.4M | ||
| Q1 25 | $17.4M | $-20.5M | ||
| Q4 24 | $17.7M | $-58.6M | ||
| Q3 24 | $18.0M | $-46.5M | ||
| Q2 24 | $24.6M | $-12.0M | ||
| Q1 24 | $27.3M | $-18.7M |
| Q4 25 | 31.1% | — | ||
| Q3 25 | -19.1% | — | ||
| Q2 25 | 31.3% | — | ||
| Q1 25 | 33.4% | — | ||
| Q4 24 | 31.5% | — | ||
| Q3 24 | 30.3% | — | ||
| Q2 24 | 33.9% | — | ||
| Q1 24 | 34.7% | — |
| Q4 25 | 9.3% | -40.0% | ||
| Q3 25 | -44.6% | -12.8% | ||
| Q2 25 | 7.2% | -9.6% | ||
| Q1 25 | 9.8% | -10.2% | ||
| Q4 24 | 8.5% | -37.4% | ||
| Q3 24 | 8.4% | -29.5% | ||
| Q2 24 | 12.9% | -8.3% | ||
| Q1 24 | 12.4% | -11.3% |
| Q4 25 | 4.3% | -19.6% | ||
| Q3 25 | -37.4% | -9.1% | ||
| Q2 25 | 2.9% | -5.7% | ||
| Q1 25 | 6.0% | -5.5% | ||
| Q4 24 | 6.2% | -15.8% | ||
| Q3 24 | 6.0% | -12.8% | ||
| Q2 24 | 7.4% | -3.2% | ||
| Q1 24 | 8.7% | -4.8% |
| Q4 25 | $0.56 | $-23.08 | ||
| Q3 25 | $-3.37 | $-9.67 | ||
| Q2 25 | $0.31 | $-6.23 | ||
| Q1 25 | $0.56 | $-6.28 | ||
| Q4 24 | $0.57 | $-23.13 | ||
| Q3 24 | $0.57 | $-15.70 | ||
| Q2 24 | $0.79 | $-7.37 | ||
| Q1 24 | $0.87 | $-7.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $112.3M | $25.0M |
| Total DebtLower is stronger | $455.7M | $228.4M |
| Stockholders' EquityBook value | $726.2M | $-155.2M |
| Total Assets | $1.7B | $656.6M |
| Debt / EquityLower = less leverage | 0.63× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $112.3M | $25.0M | ||
| Q3 25 | $108.3M | $37.7M | ||
| Q2 25 | $106.7M | $38.6M | ||
| Q1 25 | $119.4M | $40.1M | ||
| Q4 24 | $115.3M | $38.8M | ||
| Q3 24 | $127.2M | $63.0M | ||
| Q2 24 | $116.4M | $73.1M | ||
| Q1 24 | $125.4M | $27.3M |
| Q4 25 | $455.7M | $228.4M | ||
| Q3 25 | $480.6M | $252.8M | ||
| Q2 25 | $444.7M | $182.0M | ||
| Q1 25 | $416.4M | $171.1M | ||
| Q4 24 | $318.5M | $108.9M | ||
| Q3 24 | $362.2M | $133.2M | ||
| Q2 24 | $377.1M | $133.1M | ||
| Q1 24 | $439.1M | $118.1M |
| Q4 25 | $726.2M | $-155.2M | ||
| Q3 25 | $739.3M | $-18.7M | ||
| Q2 25 | $888.6M | $44.5M | ||
| Q1 25 | $900.0M | $63.3M | ||
| Q4 24 | $943.5M | $75.9M | ||
| Q3 24 | $991.0M | $120.5M | ||
| Q2 24 | $967.5M | $166.8M | ||
| Q1 24 | $967.5M | $146.6M |
| Q4 25 | $1.7B | $656.6M | ||
| Q3 25 | $1.7B | $683.6M | ||
| Q2 25 | $1.7B | $731.6M | ||
| Q1 25 | $1.7B | $783.9M | ||
| Q4 24 | $1.6B | $783.4M | ||
| Q3 24 | $1.8B | $833.3M | ||
| Q2 24 | $1.8B | $892.8M | ||
| Q1 24 | $1.8B | $855.9M |
| Q4 25 | 0.63× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.50× | 4.09× | ||
| Q1 25 | 0.46× | 2.71× | ||
| Q4 24 | 0.34× | 1.43× | ||
| Q3 24 | 0.37× | 1.11× | ||
| Q2 24 | 0.39× | 0.80× | ||
| Q1 24 | 0.45× | 0.81× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.7M | $-25.7M |
| Free Cash FlowOCF − Capex | $51.4M | — |
| FCF MarginFCF / Revenue | 16.0% | — |
| Capex IntensityCapex / Revenue | 6.9% | — |
| Cash ConversionOCF / Net Profit | 5.31× | — |
| TTM Free Cash FlowTrailing 4 quarters | $82.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.7M | $-25.7M | ||
| Q3 25 | $43.9M | $-15.4M | ||
| Q2 25 | $32.7M | $-16.6M | ||
| Q1 25 | $2.1M | $-33.5M | ||
| Q4 24 | $78.5M | $-57.2M | ||
| Q3 24 | $47.0M | $-22.6M | ||
| Q2 24 | $83.4M | $-10.2M | ||
| Q1 24 | $9.6M | $-20.0M |
| Q4 25 | $51.4M | — | ||
| Q3 25 | $25.9M | — | ||
| Q2 25 | $18.8M | — | ||
| Q1 25 | $-13.5M | — | ||
| Q4 24 | $60.2M | — | ||
| Q3 24 | $31.6M | — | ||
| Q2 24 | $63.6M | — | ||
| Q1 24 | $-17.3M | — |
| Q4 25 | 16.0% | — | ||
| Q3 25 | 9.9% | — | ||
| Q2 25 | 6.0% | — | ||
| Q1 25 | -4.7% | — | ||
| Q4 24 | 21.0% | — | ||
| Q3 24 | 10.6% | — | ||
| Q2 24 | 19.2% | — | ||
| Q1 24 | -5.5% | — |
| Q4 25 | 6.9% | — | ||
| Q3 25 | 6.9% | — | ||
| Q2 25 | 4.5% | — | ||
| Q1 25 | 5.4% | — | ||
| Q4 24 | 6.4% | 0.0% | ||
| Q3 24 | 5.2% | 0.0% | ||
| Q2 24 | 6.0% | 0.0% | ||
| Q1 24 | 8.6% | 0.0% |
| Q4 25 | 5.31× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.56× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 4.44× | — | ||
| Q3 24 | 2.61× | — | ||
| Q2 24 | 3.39× | — | ||
| Q1 24 | 0.35× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AIN
| Transferred At Point In Time | $176.5M | 55% |
| Engineered Composites Other | $99.3M | 31% |
| Engineered Composites ASC | $44.5M | 14% |
| Transferred Over Time | $1.0M | 0% |
PIII
| Capitated Revenue | $366.2M | 95% |
| Health Care Patient Service | $18.6M | 5% |
| Health Care Care Coordination Management Fees | $2.7M | 1% |
